Biomarker Webinar

view webcast

Every GIST patient is unique based on their biology and what treatment to which they will potentially respond.

Dr. Lori Rink, Fox Chase Cancer Center, and Dr. Inga-Marie Schaefer, Brigham & Women’s Hospital, are two researchers who are making discoveries in their respective laboratories to uncover the unique biomarkers in GIST that will be future drug targets.

Dr. Margaret von Mehren, Fox Chase Cancer Center, moderated the webinar and helped the audience understand why these important discoveries in the lab are important to clinicians. This concept of translational medicine is an important field as it helps bring advances into the clinic that can directly impact the survival of GIST patients.